|
Press Release
From LD
Diagnostics Co
Houston, Texas, USA
RE: The
most powerful medical measuring device in the world
FOR IMMEDIATE
RELEASE
THE EIS –
A NEW MEDICAL DEVICE AIMS TO IMPROVE HEALTHCARE EXPERIENCE
THROUGH SAFE, NONINVASIVE ELECTRO INTERSTITIAL SCANS
French
medical biosensor device now available in North America offers
10-minute, safe, noninvasive scans with no side effects and no
adverse reactions, in order to provide healthcare practitioners
with immediately available scientific assessments of the
interstitial tissues, neurological and other interrelated data
used in:
●
calculating the acid-base status of the patient’s body;
●
incredibly accurate biochemical, hormonal, and neurohormones
estimates;
●
measuring the functional status of 37 internal organs, on a
basis of 69 parameters;
● graphic
representations of conductivity of the interstitial liquid
specific of dysfunctions;
● color
coding and modeling of organ dysfunctions;
● reflection of cellular mitochondrial activity and of organic
enzymatic activity;
● reflecting interstitial pH, interstitial O2, interstitial
CO2, and ATP;
● providing interstitial Ionogram;
● computing Body Mass Index values,
● computing Body Composition values;
● providing organ system and health risk analysis in five
tiered levels;
● shows
color-coded diagrams of Auriculotherapy and Acupuncture points;:
● generate
3-D, dynamic on-screen model of a person,
● 2-D
on-screen graphs,
● 2-D
on-screen charts,
● hard
copy editable text reports.
EIS system
contains the database of 20000 patients world wide.
Millions
of people worldwide who suffer with chronic illnesses, from
diabetes to high blood pressure and heart disease to dis-ease, as
well as people who are concerned about their present health
maintenance and long-term well-being could benefit from this
state-of the-art technology.
EIS
diagnostics technology has been successfully used in many
countries in the world for over 5 years. Million scans have
been done using existing 3000 EIS units worldwide.
On March
15, 2008, LD Technology announced the availability of its EIS
Pro Medical
Device
Model and the soon-to-be-released, FDA Approved, 2nd
Generation EIS Series.
The fields
of practice benefiting from the EIS include virtually all
disciplines:
Andrology
Auricular Acupuncture
Bioenergetic medicine
Cardiology
Chiropractic
Endocrinology
Gastroenterology
General
medicine
Homeopathy
Massage
therapy
Naturopathy
Nutrition
Oncology
Pain
relief therapy
Pediatrics
Psychiatry
Psychology
Pulmonology
Sports
medicine
Therapeutic practice
Urology
Clinical
Applications include but are not limited to:
Neurologic disorders in adults and children
(Depression, ADD, ADHD, bipolar)
Detect
depression markers
Detect
bipolar markers
Detect
unipolar markers
Screening for stress factors related to
erectile
dysfunction (ED)
Screening for psychological disorders
related to
ED
3-D
modeling of neurovegetative system
Screening for psychological disorders
causing
issues
Conventional cardiovascular disorder
screenings
Microcirculation estimates
Noninvasive therapeutic follow-up of
cardiovascular treatments and adjustment of
drug doses
Bone
density estimations
Lactic
acid evaluations
Visualization of muscular excitability
Visualization of Pain
Visual
representations of organs in 3D
graphics
Estimate
muscular strength
Obesity
with Type II Diabetes
Screening for hypothyroidism
Screening for Type II Diabetes
Screening for bladder disorders
Screening for prostate disorders
Screening for renal disorders
Lifestyle and Nutritional Advice
Conventional screenings for digestive
disorders
Estimate
neurohormone status
Estimate
neurotransmitters statuses
Functional analyses and measurements of
different
organs
Assistance to doctors in diagnosis and
targeting
supplementary examinations
Verification of treatment effectiveness
Indication of possibly side effects from
pharmaceutical agents
Follow-up study of chemotherapy
effectiveness and side effects
Analysis
of therapeutic treatment and
follow-ups
Follow-up of therapies
Acupuncture and Auriculotherapy point
selection
EIS is
the only patented medical device in the world that measures in
vivo the interstitial fluid using direct current. The device,
The Electro Interstitial Scan (EIS) System, weighs less than 2
pounds and connects via a single USB port to virtually all
modern personal computers.
The EIS
device is based on over 60 years of research and is supported by
more than 6 years of clinical testing and trials. The EIS
represents a dramatic advance in today’s noninvasive healthcare
technology. It became available to medical practitioners just
after the turn of this century, in France in 2001, in Russia in
2002, throughout Europe in early
2003, in
China and parts of Asia in 2004, in Mexico and South America in
2005, in North American in 2007, and in South Africa and
Australia in early 2008.
The
benefits of the EIS, consequently, as you can see by all of the
information supplied above, include but are not limited to:
Compliance by patients is increased and supported through
visualization models appearing in the EIS
Visualization of lifestyle benefits and consequences
Visualization of dietary practices' benefits and adverse effects
Visualization of nutritional supplementation benefits and
adverse effects
Accurate
functional control measurements
Immediate study of treatment effectiveness and side effects
Immediately view biofeedback effects on neurovegetative system
Visualization as to where ischemia and/or vasoconstriction
causes pain in tissue
Provide
immediate post-procedure effects data on biochemical values
Provide
immediate post-procedure effects data on neurovegetative system
Therapeutic follow-up for hormonal thyroid treatment and
adjustment of drug doses
Follow-up of drug treatment for sterility and treatments causing
sterility
Follow-up study of possible side effects from contraceptive
pills
Aid in
the research of homeopathic remedies
Increased understanding related to the use of remedies
Study of
specific remedy implications in physiological tissue
Study of
specific remedy implications microcirculation parameters
Visualization of the therapies and methods
Noninvasive biochemical comparison studies
Macro-nutritional support
Micro-nutritional support
Provide
3-D modeling for visualization of body areas suffering in pain
Early
visualization of effectiveness and side effects of chemical
agents
Follow-up study of chemical agent effectiveness and side effects
Visualization of the results immediately following treatment
Immediate evaluation of development/recovery routine
effectiveness and consequences
How it
works. Twenty-two (22) measurements of bioelectromagnetic
impedance are taken in a variety of locations of the body in the
interstitial liquid. This interstitial liquid is located outside
the membrane of the cell and is not influenced by different
chemical buffers, as is blood. Measurements in this compartment
of the body give a true reflection of cellular activity; hence,
an organ’s activity is quantifiable. Bioimpedance or electrical
scanning of the body was established scientifically in the
1940s. It is now used in major
medical centers and research facilities for lean mass fat mass
ratio analysis, in T-scan tomography, biofeedback, and in
thoracic impedance analysis. Low voltage direct current (D.C.)
is known to pass through only interstitial fluid in the body.
The EIS system is a biosensor that analyzes the interstitial
fluid locally in vivo by application of a D.C. current between
cutaneous zones using electrodes, as stated hereinabove. In use,
the EIS introduces electric signals of low intensity (1.28V
D.C.) through the human body via 6
electrodes. This is painless and has no negative effects to the
patient. The scanned results are recorded by the EIS software
which subsequently analyzes and interprets the test results;
and, then, produces a variety of informative models, graphs, and
text data for interpretation by a medical practitioner.
The EIS
gives a comprehensive overview of the reactions of the body.
Many different 3-D models of the full body and various different
parts of the body are created, based on the electro interstitial
gram (EIG), also known as a scangram. The models are color coded
to indicate where areas of imbalance are hyper-functioning or
hypofunctioning.
The EIS
provides report screens that show interstitial biochemical
values and an evaluation of body composition including lean
mass, fat mass, and hydration data. Measurements are further
extrapolated to provide report screens with hormone,
electrolyte, neurotransmitter, and oxidative stress analyses.
Assistance is also provided to the practitioner with suggestions
for further medical tests for the patient, personalized diet,
and micro-nutrition, vitamin, and trace element (oligotherapy)
advice. No pharmaceutical agents are suggested, though.
After any
treatment is instituted, follow-up visits and tests can monitor
treatment effectiveness; and, any side effects during treatment
and patient recovery can also be (immediately) monitored. The
system is free of practitioner input and bias.
.
Before
reaching the U.S. marketplace, the EIS was calibrated using over
20,000 clinical study tests from individuals and subsequent
tests from patients with a wide-variety of pathologies. Some of
the testing facilities included:
Botkin
Hospital - studies validated algorithms for cardiovascular, respiratory,
digestive, endocrine, and neurological pathologies.
Beijing
University Hospital - tests
validated algorithms in oncology screening and therapeutic
monitoring.
Gustave
Roussy and St Louis Hospitals, Paris - tests were performed to
validate algorithms for oncological monitoring in patients aged
between 16 months and 4 years, and andrology
.
Harvard
Medical School – Bipolar, ADHD,
unipolar, depression tests
The latest
clinical tests in 2007 showed that follow-up is reliable and
diagnostic EIS results are accurate, when compared to
conventional examination results.
The EIS is
in use in more than 25 countries, approximately 6,000 tests are
made every day, and doctors, hospitals, and practitioners that
use the device daily have always given very favorable feedback.
This
device is ISO 9001 approved and has European regulatory approval
CE 0459. Approvals have also issued in Israel, Korea, China, and
Canada. This patented medical measuring technology has no
competitor.
For
information on EIS medical device please contact LD Diagnostics
Co in Houston, Texas,USA at 832-641-5179.
bodyscandiagnostics@yahoo.com
www.bodyscandiagnostics.com
|